Xtant Medical Holdings (XTNT) Amortizatization of Intangibles (2011 - 2015)
Xtant Medical Holdings' (XTNT) quarterly Amortizatization of Intangibles came in at -$141492.0 in Q3 2015, down 130.19% year-over-year from $468732.0 in Q3 2014, and down 133.34% quarter-over-quarter from $424386.0 in Q2 2015.
Powered by 
Analysis
Xtant Medical Holdings (XTNT) Amortizatization of Intangibles (2011 - 2015) Analysis & Trends
Xtant Medical Holdings (XTNT) has reported Amortizatization of Intangibles for 5 consecutive years, with -$141492.0 the latest figure, recorded in Q3 2015.
- On a quarterly basis, Amortizatization of Intangibles fell 130.19% year-over-year to -$141492.0 in Q3 2015; TTM through Mar 2016 was $282894.0, a 83.34% decrease from a year earlier, with the FY2015 full-year figure at $707281.0, down 56.67% from the prior year.
- Amortizatization of Intangibles was -$141492.0 for Q3 2015 at Xtant Medical Holdings, down from $424386.0 in the prior quarter.
- Over five years, Amortizatization of Intangibles peaked at $1.0 million in Q3 2011 and troughed at -$1.0 million in Q4 2011.
- A 5-year average of $242773.5 and a median of $333972.0 in 2013 frame the typical range for Amortizatization of Intangibles.
- Across the five-year window, Amortizatization of Intangibles soared 1143.7% in 2013 and tumbled 130.19% in 2015, its largest moves.
- Over 5 years, Amortizatization of Intangibles stood at -$1.0 million in 2011, then jumped by 127.21% to $273539.0 in 2012, then grew by 22.09% to $333972.0 in 2013, then increased by 27.07% to $424386.0 in 2014, then sank by 133.34% to -$141492.0 in 2015.
- The last three Amortizatization of Intangibles figures came in at -$141492.0 (Q3 2015), $424386.0 (Q2 2015), and $424387.0 (Q1 2015), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | - |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | 38.80 Mn |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | - |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | - |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | - |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | 6.60 Mn |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | - |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | - |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | - |
| 10 | Xtant Medical Holdings | 47.61 Mn | 30.01 Mn | 17.75 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2015 | -141,492.00 |
| Jun 30, 2015 | 424,386.00 |
| Mar 31, 2015 | 424,387.00 |
| Dec 31, 2014 | 424,386.00 |
| Sep 30, 2014 | 468,732.00 |
| Jun 30, 2014 | 380,040.00 |
| Mar 31, 2014 | 359,087.00 |
| Dec 31, 2013 | 333,972.00 |
| Sep 30, 2013 | 333,972.00 |
| Jun 30, 2013 | 333,972.00 |
| Mar 31, 2013 | 249,209.00 |
| Dec 31, 2012 | 273,539.00 |
| Sep 30, 2012 | 174,798.00 |
| Jun 30, 2012 | 26,853.00 |
| Mar 31, 2012 | 26,854.00 |
| Dec 31, 2011 | -1.01 Mn |
| Sep 30, 2011 | 1.04 Mn |